Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease

Brain Research

Volumn 1433, Issue , 2012, Pages 104-113

  Anandhan, Annadurai ^a   Tamilselvam, Kuppusamy ^a   Radhiga, Thangaiyan ^a   Rao, Shalinee ^b   Essa, Musthafa Mohamed ^c   Manivasagam, Thamilarasan ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

1 methyl 4 phenyl 1, 2, 3, 6 tetrahydropyridine probenecid (MPTP p); Apoptosis; Dopamine transporter; Theaflavin; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BLACK TEA EXTRACT; CASPASE 3; CASPASE 8; CASPASE 9; DOPAMINE TRANSPORTER; POLYPHENOL; PROBENECID; THEAFLAVIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BIFLAVONOIDS; CATECHIN; DOPAMINERGIC NEURONS; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; PILOT PROJECTS; POLYPHENOLS; PROBENECID; RANDOM ALLOCATION; SUBSTANTIA NIGRA; TEA;

CAMELLIA SINENSIS; MUS;

EID: 84855204111     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.11.021     Document Type: Article

References (56)

1. V. Anantharam, E. Lehrmann, K. Kanthasamy, Y. Yang, P. Banerjee, K.G. Becker, W.J. Freed, and A.G. Kanthasamy Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease Neurochem. Int. 50 2007 834 847 (Pubitemid 46722646)
2. S. Banerjee, P. Maity, S. Mukherjee, A.K. Sil, K. Panda, D. Chattopadhyay, and I.B. Chatterjee Black tea prevents cigarette smoke-induced apoptosis and lung damage J. Inflamm. (Lond.) 4 2007 3
3. W. Birkmayer, and O. Hornykiewicz The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia Wien. Klin. Wochenschr. 73 1961 787 788
4. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172 (Pubitemid 32524182)
5. F. Cai, C.R. Li, J.L. Wu, J.G. Chen, C. Liu, Q. Min, W. Yu, C.H. Ouyang, and J.H. Chen Theaflavin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-inflammatory effect and modulation of STAT-1 Mediators Inflamm. 2006 2006 1 9
6. M. Caruana, T. Högen, J. Levin, A. Hillmer, A. Giese, and N. Vassallo Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds FEBS Lett. 585 2011 1113 1120
7. R.K. Chaturvedi, S. Shukla, K. Seth, S. Chauhan, C. Sinha, Y. Shukla, and A.K. Agrawal Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease Neurobiol. Dis. 22 2006 421 434
8. +, a metabolite of MPTP, by brain synaptosomes Biochem. Biophys. Res. Commun. 128 1985 1228 1232 (Pubitemid 15008275)
9. J.S. Choi, Y.J. Choi, S.Y. Shin, J. Li, S.W. Kang, J.Y. Bae, D.S. Kim, G.E. Ji, J.S. Kang, and Y.H. Kang Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling J. Nutr. 138 2008 983 990 (Pubitemid 351769118)
10. Y.G. Choi, J.H. Park, and S. Lim Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model Neurosci. Lett. 450 2009 92 96
11. J.C. Crabbe, P. Metten, C.H. Yu, J.P. Schlumbohm, A.J. Cameron, and D. Wahlsten Genotypic differences in ethanol sensitivity in two tests of motor incoordination J. Appl. Physiol. 95 2003 1338 1351 (Pubitemid 37169276)
12. S.J. Crocker, P. Liston, H. Anisman, C.J. Lee, P.D. Smith, N. Earl, C.S. Thompson, D.S. Park, R.G. Korneluk, and G.S. Robertson Attenuation of MPTP-induced neurotoxicity and behavioral impairment in NSE-XIAP transgenic mice Neurobiol. Dis. 12 2003 150 161 (Pubitemid 36349406)
13. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
14. Y. Du, R.C. Dodel, K.R. Bales, R. Jemmerson, E. Hamilton-Byrd, and S.M. Paul Involvement of a caspase-3-like cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons J. Neurochem. 69 1997 1382 1388 (Pubitemid 27406938)
15. C.J. Dufresne, and E.R. Farnworth A review of latest research findings on the health promotion properties of tea J. Nutr. Biochem. 7 2001 404 421 (Pubitemid 32633828)
16. P.O. Fernagut, E. Diguet, B. Labattu, and F. Tison A simple method to measure stride length as an index of nigrostriatal dysfunction in mice J. Neurosci. Methods 113 2002 123 130 (Pubitemid 34076535)
17. S.M. Fleming, J. Salcedo, P.O. Fernagut, E. Rockenstein, E. Masliah, M.S. Levine, and M.F. Chesselet Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein J. Neurosci. 24 2004 9434 9440 (Pubitemid 39426179)
18. B. Frei, and J.V. Higdon Antioxidant activity of tea polyphenols in vivo: evidence from animal studies J. Nutr. 133 2003 3275 3284
19. R.M. Friedlander Apoptosis and caspases in neurodegenerative diseases N. Engl. J. Med. 348 2003 1365 1375 (Pubitemid 36384105)
20. T. Hanakawa, Y. Katsumi, H. Fukuyuma, M. Honda, T. Hayashi, J. Kimura, and H. Shibasaki Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study Brain 122 1999 1271 1282 (Pubitemid 29324848)
21. A. Hartmann, S. Hunot, P.P. Michel, M.P. Muriel, S. Vyas, B.A. Faucheux, A. Mouatt-Prigent, H. Turmel, A. Srinivasan, M. Ruberg, G.I. Evan, Y. Agid, and E.C. Hirsch Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 97 2000 2875 2880 (Pubitemid 30159265)
22. A. Hartmann, J.D. Troadec, S. Hunot, K. Kikly, B.A. Faucheux, A. Mouatt- Prigent, M. Ruberg, Y. Agid, and E.C. Hirsch Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis J. Neurosci. 21 2001 2247 2255 (Pubitemid 32240523)
23. R.E. Heikkila, L. Manzino, F.S. Cabbat, and R.C. Duvoisin Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine by monoamine oxidase inhibitors Nature 311 1984 467 469 (Pubitemid 14035453)
24. K. Ishige, D. Schubert, and Y. Sagara Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms Free Radic. Biol. Med. 30 2001 433 446 (Pubitemid 32155542)
25. V. Jackson-Lewis, M. Jakowec, R.E. Burke, and S. Przedborski Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Neurodegeneration 4 1995 257 269
26. H. Jiang, N. Song, J. Wang, L. Ren, and J. Xie Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra Neurochem. Int. 51 2007 32 36 (Pubitemid 47002045)
27. Y. Kuroda, and Y. Hara Antimutagenic and anticarcinogenic activity of tea polyphenols Mutat. Res. 436 1999 69 97 (Pubitemid 29044047)
28. R. Kurosaki, Y. Muramatsu, H. Watanabe, M. Michimata, M. Matsubara, Y. Imai, and T. Araki Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice Metab. Brain Dis. 18 2003 139 146 (Pubitemid 36718126)
29. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980 (Pubitemid 13189531)
30. Y.S. Lau, L. Novikova, and C. Roels MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non treated cagemates through close contact Neurosci. Res. 52 2005 371 378 (Pubitemid 40917216)
31. Y.S. Lau, G. Patki, K. Das-Panja, W.D. Le, and S.O. Ahmad Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration Eur. J. Neurosci. 33 2011 1264 1274
32. L.K. Leung, Y. Su, R. Chen, Z. Zhang, Y. Huang, and Z.Y. Chen Theaflavins in black tea and catechins in green tea are equally effective antioxidants J. Nutr. 131 2001 2248 2251 (Pubitemid 32851864)
33. Y. Levites, O. Weinreb, G. Maor, M.B. Youdim, and S. Mandel Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration J. Neurochem. 78 2001 1073 1082 (Pubitemid 32823156)
34. Y. Levites, M.B. Youdim, G. Maor, and S. Mandel Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures Biochem. Pharmacol. 63 2002 21 29 (Pubitemid 34075289)
35. S. Li, and X.P. Pu Neuroprotective Effect of Kaempferol against a 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease Biol. Pharm. Bull. 34 2011 1291 1296
36. B. Liu, J.X. Xie, L.L. Tsang, D.K. Rowlands, L.S. Ho, Y.L. Gou, Y.W. Chung, and H.C. Chan Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity Cell Biol. Int. 32 2008 86 92 (Pubitemid 351249143)
37. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
38. L.D. Mercer, B.L. Kelly, M.K. Horne, and P.M. Beart Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures Biochem. Pharmacol. 69 2005 339 345 (Pubitemid 41556580)
39. M. Mohanasundari, M.S. Srinivasan, S. Sethupathy, and M. Sabesan Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice J. Neurol. Sci. 249 2006 140 144 (Pubitemid 44665916)
40. R. Moldzio, K. Radad, J.C. Duvigneau, B. Kranner, C. Krewenka, C. Piskernik, and W.D. Rausch Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture J. Neural Transm. 113 2006 1095 1105 (Pubitemid 44291006)
41. E. Petroske, G.E. Meredith, S. Callen, S. Totterdell, and Y.S. Lau Mouse model of parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment Neuroscience 106 2001 589 601 (Pubitemid 32925247)
42. S. Przedborski, and M. Vila The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease Ann. N. Y. Acad. Sci. 991 2003 189 198 (Pubitemid 36793814)
43. S. RajaSankar, T. Manivasagam, and S. Surendran Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease Neurosci. Lett. 454 2009 11 15
44. R.R. Ramsay, and T.P. Singer Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine, by mitochondria J. Biol. Chem. 261 1986 7585 7587 (Pubitemid 17208669)
45. W.D. Rausch, Y. Hirata, T. Nagatsu, P. Riederer, and K. Jellinger Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease, effects of iron and phosphorylating agents J. Neurochem. 50 1988 202 208 (Pubitemid 18023500)
46. G. Rozas, E. Lopez-Martin, M.J. Guerra, and J.L. Labandeira-Garcia The overall rod performance test in the MPTP-treated mouse model of Parkinsonism J. Neurosci. Methods 83 1998 165 175 (Pubitemid 28442608)
47. J.S. Schneider, A. Yuwiler, and C.H. Markham Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP Brain Res. 411 1987 144 150 (Pubitemid 17084779)
48. M. Sedelis, K. Hofele, G.W. Auburger, S. Morgan, J.P. Huston, and R.K. Schwarting MPTP susceptivility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences Behav. Genet. 30 2000 171 182
49. J. Segura Aguilar, and R.M. Kostrzewa Neurotoxins and neurotoxic species implicated in neurodegeneration Neurotox. Res. 6 2004 615 630
50. A. Seidi, H. Kaji, N. Annabi, S. Ostrovidov, M. Ramalingam, and A. Khademhosseini A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson's disease Biomicrofluidics 2 2011 22214 (Epub 2011 Jun 29)
51. E.K. Tan, C. Tan, S.M. Fook-Chong, S.Y. Lum, A. Chai, H. Chung, H. Shen, Y. Zhao, M.L. Teoh, Y. Yih, R. Pavanni, V.R. Chandran, and M.C. Wong Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese J. Neurol. Sci. 216 2003 163 167 (Pubitemid 37376408)
52. T. Thomas, M. Timmer, K. Cesnulevicius, E. Hitti, A. Kotlyarov, and M. Gaestel MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation-relevance in a mouse model of Parkinson's disease J. Neurochem. 105 2008 2039 2052 (Pubitemid 351678515)
53. R. Tinter, and J. Jankovic Treatment options for Parkinson's disease Curr. Opin. Neurol. 15 2002 467 476 (Pubitemid 34828125)
54. V. Viswanath, Y.Q. Wu, R. Boonplueang, S. Chen, F.F. Stevenson, F. Yantiri, L.C. Yang, M.F. Beal, and J.K. Andersen Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1 2,3,6-tetrahydropyridine-induced Parkinson's disease J. Neurosci. 21 2001 9519 9528 (Pubitemid 34184040)
55. Y. Watanabe, T. Himeda, and T. Araki Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease Med. Sci. Monit. 11 2005 17 23
56. A.M. Wright, J. Bempong, M.L. Kirby, R.L. Barlow, and J.R. Bloomquist Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia Brain Res. 788 1998 215 222 (Pubitemid 28202164)